Contract Option Exercises — August 21, 2026

CACI secured a $674.4M cost-plus-fixed-fee delivery order under full and open competition, providing predictable, lower-margin-risk revenue for federal IT modernization through 2024.

The $371.5M NASA ISS support contract ended December 2022 with only $151.3M outlayed (41% utilization), indicating potential under-execution or delayed spending; no follow-on work is visible.

The total outlayed amount on CACI's contract is -$414,919, which is unusual and may signal early-stage accounting credits or adjustments that could affect reported revenue recognition.

The $263.6M obligated (up to $1.04B total) cost-plus-fixed-fee contract for Marburg virus R&D through 2036 indicates long-term government commitment to biodefense, potentially benefiting subcontractors in the biotech supply chain.

Highrise Consulting has outlayed $89.6M (65%) of its $138.6M NIH IT delivery order with 5-year performance through 2027, indicating high utilization and low cancellation risk for cloud services.

CACI's $674M GSA contract shows a negative net outlay (-$414,919), which may indicate accounting adjustments or early-stage performance issues that could distort revenue recognition in upcoming quarters.

Teledyne Brown Engineering's $372M NASA contract expired with only 41% outlayed, suggesting potential budget reallocation or program delays; no follow-on contract is evident, creating a revenue gap.

HSGS-AMERESCO's $149M VA energy savings contract is set aside for SDVOSBs, limiting competition but also capping scalability; fixed-price structure introduces performance risk if energy savings fall short.

Only 1 of 6 contracts (17%) is defense-related, indicating this stream is heavily skewed toward civilian agencies, which may face different budget pressures under a Continuing Resolution.

CACI's $674M GSA IT contract and Highrise Consulting's $139M NIH cloud contract both indicate sustained demand for civilian IT modernization, creating growth opportunities for IT services firms like CACI, Booz Allen, and Leidos.

The low defense representation (1 of 6 contracts) suggests potential for increased defense spending if a full-year appropriations bill passes, benefiting defense primes like Lockheed Martin and Northrop Grumman.

HSGS-AMERESCO's $149M SDVOSB set-aside from the VA highlights policy-driven opportunities for veteran-owned small businesses in energy efficiency, potentially benefiting other SDVOSB contractors.

BARDA's $1.04B biodefense contract to Sabin Vaccine Institute signals long-term government commitment to pandemic preparedness, creating subcontracting opportunities for publicly traded biotech firms in vaccine development and manufacturing.

Two contracts—CACI's $674M GSA IT services award and Highrise Consulting's $139M NIH cloud support contract—total $813M in civilian IT spending, indicating strong and sustained demand for third-party IT support across non-defense agencies.

Teledyne Brown Engineering's $372M NASA ISS contract expired with only 41% outlayed, suggesting potential underfunding or program reprioritization that could affect other NASA support contractors.

BARDA's $1.04B Marburg virus contract to Sabin Vaccine Institute demonstrates sustained government investment in biodefense, with cost-plus pricing reducing contractor risk.

{"entity" => "CACI International Inc.", "reason" => "Negative net outlay on $674M GSA contract requires clarification; contract ends May 2024, creating recompete risk.", "trigger" => "CACI earnings call for contract profitability discussion; GSA recompete announcement for Communication and Information Technology Services III"}

{"entity" => "Teledyne Brown Engineering", "reason" => "Expired $372M NASA contract with low utilization creates revenue gap; no follow-on work visible.", "trigger" => "NASA ISS operations budget release; new NASA task orders for mission operations support"}

{"entity" => "HSGS-AMERESCO, LLC", "reason" => "Fixed-price VA ESPC contract with SDVOSB set-aside; option exercise by February 2027 is key catalyst.", "trigger" => "Option exercise announcement by February 2027; VA ESPC budget allocation"}

{"entity" => "Albert B. Sabin Vaccine Institute", "reason" => "Large BARDA contract with $1.04B potential value; subcontract awards to publicly traded biotech firms could create investment opportunities.", "trigger" => "Option exercise announcements; subcontract award disclosures to publicly traded firms"}

{"entity" => "Highrise Consulting Inc", "reason" => "Strong execution on $139M NIH IT contract with 65% outlayed; renewal risk in September 2027.", "trigger" => "NIH budget for IT and cloud services; contract renewal or follow-on award in 2027"}